Showing 31 - 40 of 7,692
Persistent link: https://www.econbiz.de/10010609355
In 2007, the David and Lucile Packard Foundation established Insuring America's Children to help secure health care for all children. A new brief and executive summary document how state-based grantees responded and adapted to unprecedented changes in children's coverage over the past several...
Persistent link: https://www.econbiz.de/10010609414
This chartbook provides a snapshot of Medicaid pharmacy benefit use and reimbursement in 2003 and shows key trends from 1999 to 2003.
Persistent link: https://www.econbiz.de/10011100689
The Medicare Part D coverage gap has been associated with lower adherence and drug utilization and higher discontinuation. Because osteoporosis has a relatively high prevalence among Medicare-eligible postmenopausal women, we examined changes in utilization of osteoporosis medications during...
Persistent link: https://www.econbiz.de/10011100725
This chartbook, prepared for the Centers for Medicare & Medicaid Services, presents highlights and key comparisons from the state-by-state and national tables in the statistical compendium on Medicaid pharmacy benefit use and reimbursement in 2007.
Persistent link: https://www.econbiz.de/10011100950
This issue brief highlights a number of prescription drug issues that remain important for states after the shift of prescription drug coverage for Medicaid-Medicare dual eligibles to Medicare in 2006, including the use of antipsychotic drugs in nursing facilities and other settings. It focuses...
Persistent link: https://www.econbiz.de/10011100985
This chartbook highlights national and state-by-state data on Medicaid prescription drug use and expenditures for 2005 by beneficiary characteristics (age, sex, and race), basis of eligibility (children, adults, disabled, and aged), and type of drug (brand vs. generic, top 10 drug groups, top 7...
Persistent link: https://www.econbiz.de/10011101082
To compare healthcare costs associated with initiating treatment on escitalopram or an alternative selective serotonin reuptake inhibitor.
Persistent link: https://www.econbiz.de/10011101227
Persistent link: https://www.econbiz.de/10011101342
Persistent link: https://www.econbiz.de/10011101655